Last reviewed · How we verify

NCT07529366

Pharmacist-Led Continuous Glucose Monitoring for Prediabetes

Recruiting now Last updated 14 April 2026
What this trial tests

trial testing Dexcom Stelo CGM in Prediabetes in 40 participants. Currently enrolling.

Timeline
1 June 2026
Primary endpoint
31 July 2027
31 July 2027

Quick facts

Lead sponsorUniversity of South Florida
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment40
Start date1 June 2026
Primary completion31 July 2027
Estimated completion31 July 2027
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of South Florida

Who can join

Adults 18 to 70, any sex, with Prediabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to determine if a pharmacist-led program involving continuous glucose monitoring (CGM) improves glucose control and health behavior in people with prediabetes. The main questions it aims to answer are: 1. Determine impact of pharmacist-led CGM on glycemic control in people with prediabetes. Researchers will compare change in hemoglobin A1c at 12 weeks with pharmacist-led CGM versus a historical cohort of subjects with prediabetes receiving no CGM. We will also assess change in CGM-derived glycemic metrics from baseline to end of the CGM wear period in the intervention group. 2. Evaluate impact of pharmacist-led CGM on health behavior change in people with prediabetes in the intervention group. Participants will be asked to complete the Summary of Diabetes Self-Care Activities Measure (SDSCA) and 36-Item Short Form Health Survey (SF-36) at baseline, at the end of week 4, and at the end of the study so that researchers can measure the effects in the intervention group on health behavior change.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Prediabetes

Currently open trials in the same condition.

Other University of South Florida trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07529366.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing